Abstract | PURPOSE: PROCEDURES:
Sigma-1 receptor occupancy (RO) in the rat brain by cutamesine was determined using 1-[2-(3,4-dimethoxyphenethyl)]-4-(3-phenylpropyl) piperazine ([(11)C] SA4503) and positron emission tomography (PET), and tissue cutamesine levels were measured by ultra performance liquid chromatography (UPLC)-MS. RO was calculated from a Cunningham-Lassen plot, based on the total distribution volume of [(11)C] SA4503 determined by Logan graphical analysis. Cognitive performance was assessed using the passive avoidance (PA) test. RESULTS:
Cutamesine at a dose of 1.0 mg/kg reversed REM SD-induced cognitive deficit and occupied 92 % of the sigma-1 receptor population. A lower dose (0.3 mg/kg) occupied 88 % of the receptors but did not significantly improve cognition. CONCLUSION: The anti-amnesic effect of cutamesine in this animal model may be related to longer exposure at a higher dose and/or drug binding to secondary targets.
|
Authors | Nisha K Ramakrishnan, Marianne Schepers, Gert Luurtsema, Csaba J Nyakas, Philip H Elsinga, Kiichi Ishiwata, Rudi A J O Dierckx, Aren van Waarde |
Journal | Molecular imaging and biology
(Mol Imaging Biol)
Vol. 17
Issue 3
Pg. 364-72
(Jun 2015)
ISSN: 1860-2002 [Electronic] United States |
PMID | 25449772
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Piperazines
- Receptors, sigma
- sigma-1 receptor
- Citalopram
- SA 4503
|
Topics |
- Animals
- Brain
(diagnostic imaging, metabolism)
- Chromatography, High Pressure Liquid
(methods)
- Citalopram
(therapeutic use)
- Cognition
- Male
- Mass Spectrometry
- Memory Disorders
(drug therapy)
- Piperazines
(chemistry)
- Positron-Emission Tomography
- Protein Binding
- Rats
- Rats, Wistar
- Receptors, sigma
(agonists)
- Sleep Deprivation
(drug therapy)
- Sleep, REM
(drug effects)
|